Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found two records

$400,000.00

Jan 1, 2020

For-profit organization

Agreement:

Development of Cannabis and Nutraceutical infused QuickStrip Products

Agreement Number:

935556

Duration: from Jan 1, 2020 to Dec 31, 2021
Description:

Rapid Dose Therapeutics Corp. (RDT) is a publicly traded Canadian life science company (CSE: DOSE) that develops innovative, proprietary drug delivery technologies designed to improve health and wellness outcomes and improve quality of life.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Burlington, Ontario, CA L7N 2G4

$24,500.00

Jun 17, 2019

For-profit organization

Agreement:

YEP - Design and development of novel biopolymer compositions for oral dispersible thin films for enhanced mucosal delivery and rapid uptake of medicinal active agents.

Agreement Number:

931323

Duration: from Jun 17, 2019 to Feb 28, 2020
Description:

QuickStrip™ is a proprietary oral thin film delivery method developed by Rapid Dose Therapeutics, which is designed for rapid uptake of therapeutic ingredients directly into the bloodstream. The film consists of micronized active ingredient that is evenly dispersed throughout a rapidly dissolving film matrix. The goals of this project are to optimize the current QuickStrip™ formulation, as well as develop new product formulations in respond to customer needs and new market opportunities in both human health and animal health applications.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Youth Employment Program
Location: Burlington, Ontario, CA L7N 2G3